您的位置:首页 > 产品中心 > 799279-67-7, C18 LPA
C18 LPA

| 产品编号: | 4070949 |
| 规格: | 1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt), powder |
| CAS NO: | 799279-67-7 |
| 包装规格: | 1 MG |
| 产品类别: | 进口试剂 |
| 品牌: | Avanti |
| 优惠价: | 立即咨询 |
产品别名
799279-67-7
C18 LPA
1-octadecyl-sn-glycero-3-phosphate (ammonium salt); PA(18:0e/0:0)
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C21H48NO6P |
| Molecular weight | 441.58 |
| NACRES | NA.25 |
| General description【一般描述】 | Lysophosphatidic acid (LPA) is a class of phospholipids, which is water-soluble. It has a glycerol backbone attached via a phosphate group, an aliphatic chain and a hydroxyl group. The aliphatic chain is linked to either sn-1 or sn-2 position and the phosphate group is connected to the sn-3 position. The hydroxyl group is linked to the remaining sn-1 or sn-2 position. |
| Application【应用】 | C18 LPA or 1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphate may be used:
|
| Biochem/physiol Actions【生化/生理作用】 | Lysophosphatidic acid (LPA) is a signaling molecule and alters various cellular responses through G protein-coupled receptors (GPCRs). It stimulates smooth muscle contraction, cytoskeleton rearrangement and chemotaxis. LPA is also involved in inducing neurotransmitter release, cell proliferation, platelet aggregation and Ca2+ mobilization. Increased levels of LPA in human plasma leads to ovarian cancer and atherosclerosis. LPA acts as a potential biomarker for ovarian cancer. |
产品性质
| Assay【测定】 | >99% (LPA; may contain up to 10% of the 2-LPA isomer) |
| form【形式】 | powder |
| manufacturer/tradename | Avanti Polar Lipids 857228P |
| shipped in【运输】 | dry ice |
| storage temp.【储存温度】 | −20℃ |
| SMILES string | O[C@](COP([O-])(O)=O)([H])COCCCCCCCCCCCCCCCCCC.[NH4+] |
| packaging【包装】 | 5 mL Amber Glass Screw Cap Vial (857228P-1mg) |
安全信息
| Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |
| WGK | WGK 3 |




